Joseph Horrigan
Director Técnico/Científico/I+D en AMO Pharma Ltd. .
Perfil
Joseph Horrigan is currently an Associate Professor at The University of North Carolina at Charlotte and the Chief Medical Officer at AMO Pharma Ltd.
He previously worked as the VP-Clinical Development & Medical Affairs at Neuren Pharmaceuticals Ltd.
He earned a doctorate degree from the University of Rochester.
Cargos activos de Joseph Horrigan
| Empresas | Cargo | Inicio |
|---|---|---|
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - |
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Director Técnico/Científico/I+D | - |
Antiguos cargos conocidos de Joseph Horrigan.
| Empresas | Cargo | Fin |
|---|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Director Técnico/Científico/I+D | - |
Formación de Joseph Horrigan.
| Rochester Christian University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NEUREN PHARMACEUTICALS LIMITED | Health Technology |
| Empresas privadas | 1 |
|---|---|
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Joseph Horrigan
